Unable to sell Sputnik Light stock, Stelis Biopharma asks PM Modi for procurement of jabs
Arun Kumar requested that the government should acquire the available doses, failing which these will get wasted and the company will face a huge financial loss.;
Advertisement
New Delhi: Unable to sell its huge stock of COVID vaccine Sputnik Light amid the Russia-Ukraine conflict, the Bengaluru-based Stelis Biopharma has written to Prime Minister Narendra Modi requesting for procurement of the jabs for inoculating citizens here or supplying to other countries under the Vaccine Maitri programme.
Stelis Biopharma, the biopharmaceutical arm of Strides Pharma Science, said it could not sell 2.5 crore units of the single-dose vaccine manufactured by it due to several constraints following the Russian-Ukraine war.
Read also: Stelis Biopharma, RDIF collaborate to supply 200 million Sputnik V doses
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.